The global mesotherapy market is distinguished by the presence of numerous global, regional, and local players catering to mesotherapy techniques that are evolving at a rapid pace. Furthermore, the increasing prevalence of skin problems and hair loss is further driving the growth of the global mesotherapy market during the forecast period. The major players have adopted a strategy of obtaining regulatory approval from government agencies for their products and signing contracts and agreements to broaden their reach and reduce operational costs. For instance, in May 2020, Galderma received the Food and Drug Administration (FDA) approval for its Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21. The FDA's acceptance of Restylane Contour adds to Galderma Laboratories, L. P’s expanding line of Restylane products.
The global mesotherapy market is extremely competitive, with players competing, partnering, and investing heavily in research and development to gain a significant market share. The market is moderately fragmented with rising competition, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency.
The growth of prominent industry players is dependent on various factors, such as market conditions, government support, and industry development. Key manufacturers in the mesotherapy market are focusing on developing products. It is also projected that a rise in the investments for R&D will also boost the market's growth in the upcoming future.
With respect to the current scope of the report, AbbVie Inc. (US) is the top player in the global mesotherapy market due to its strong product offering. Galderma Laboratories, L.P. (US) is the second major player, followed by FILORGA (France), Koru Pharmaceuticals Co., LTD. (South Korea), Toskani Cosmetics (Spain), Mesoskinline (Denmark), Fusion Meso (Spain), Dermoaroma (Italy), Messoessence (Spain), Institute BCN (Spain).
Threat of New Entrants
Any manufacturing company trying to enter the market is required to accept and abide by the mandatory regulatory standards set by regulatory bodies such as the Food and Drug Administration (FDA), European Medicines Agency (EMA), and others across region. Moreover, ambiguous regulatory scenarios in some regions make it difficult for new entrants to enter the market. However, as the demand for minimally invasive cosmetic procedures increase, new players are expected to enter to cater to the demand. Thus, the overall threat of new entrants in the global mesotherapy markets is projected to be moderate during the forecast period.
Bargaining Power of Suppliers
There are fewer players than there are consumers, which makes it easier for suppliers to establish themselves in this market. Furthermore, mesotherapy suppliers place a premium on the uniqueness of their products in terms of efficacy, effectiveness, and results. Additionally, mesotherapy providers aim to obtain high quality materials that are approved by regulatory bodies which further increase the bargaining power of suppliers. Hence, the bargaining power of suppliers in the global mesotherapy markets is high during the forecast period.
Threat of Substitutes
Substitutes pose a high threat in the mesotherapy market due to the availability of alternatives to mesotherapy including other non-surgical and surgical cosmetic procedures which aim to provide similar results, which are more accessible and popular among the consumers.
Bargaining Power of Buyers
The low number of manufacturers offering quality mesotherapy products which decreases the power of buyers. However, the switching cost of products is moderate. Since, the products can also lead to certain risks associated with the procedure, a significant level of brand loyalty is also observed in the market. Thus, the bargaining power of buyers is projected to be moderate in the global mesotherapy market during the forecast period.
Intensity of Rivalry
There is lack of products with comparable efficacy and safety from market competitors. The demand for the products is high owing to the increasing prevalence of incidences of skin disease such as cellulite and rising public aesthetic awareness. Furthermore, the lack of significant price differences increases the intensity of rivalry. There are fewer players and products available in the market, and due to this, the competition for mesotherapy seems moderate. Furthermore, there is high competition among the players to provide products that give better results which will aid in product adoption. Thus, the competition among players is overall moderate.
